Technical and market analysis related to gpt-rosalind.
GPT Image 2, GPT Realtime, and GPT-Rosalind show that the hard problem shifts from capability to permissions, responsibility, data boundaries, and evaluation.
Read analysisGPT Image 2, GPT Realtime, and GPT-Rosalind point to the same shift: OpenAI is splitting frontier capability into specialized surfaces that fit real work.
Read analysisOpenAI anchors scientific AI to workflows with LifeSciBench, then picks an FDA surrogate-endpoint case that mirrors Elevidys — exposing the real test for domain models: will they say the evidence isn't enough, exactly where the experts didn't agree?
Read analysis